Product mentioned on podcasts
suzutamig
by Candid Therapeutics
Mentioned on 1 episode by 1 guest across our covered podcasts.
SignalCast may earn commission on purchases via these links.
Who mentioned it
- Ken SongAuthor
“Early clinical data from Candid's BCMA T-cell engager, suzutamig, shows that one treatment cycle — four weekly injections administered within 30 days — can produce durable immune reset in autoimmune patients.”
Mentioned on: The Long Run with Luke Timmerman